Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage

Clinics and Research in Hepatology and Gastroenterology

Volumn 41, Issue 2, 2017, Pages 147-155

  Bao, Suxia ^a   Zheng, Jianming ^a   Li, Ning ^a   Huang, Chong ^a   Chen, Mingquan ^a   Cheng, Qi ^a   Li, Qian ^a   Lu, Qing ^a   Zhu, Mengqi ^a   Ling, Qingxia ^a   Yu, Kangkang ^a   Chen, Shengshen ^a   Shi, Guangfeng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VIRUS DNA; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR; TIFAB PROTEIN, HUMAN;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ACTIVATION; CELL ISOLATION; CHRONIC HEPATITIS B; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY ANALYZER; IMMUNOLOGICAL TOLERANCE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; BLOOD; CHEMISTRY; IMMUNOLOGY; LIVER; MORTALITY; PATHOLOGY; PHYSIOLOGY;

ACUTE-ON-CHRONIC LIVER FAILURE; ADULT; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; LIVER; MALE; MONOCYTES; NF-KAPPA B; RECEPTORS, INTERLEUKIN; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 85009851663     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2016.10.005     Document Type: Article

References (25)

1. [1] McMahon, B.J., The natural history of chronic hepatitis B virus infection. Hepatology 49:5 Suppl. (2009), S45–S55.
2. [2] Wu, J.F., Chang, M.H., Natural history of chronic hepatitis B virus infection from infancy to adult life – the mechanism of inflammation triggering and long-term impacts. J Biomed Sci, 22, 2015, 92.
3. [3] Balmasova, I.P., Yushchuk, N.D., Mynbaev, O.A., Alla, N.R., Malova, E.S., Shi, Z., et al. Immunopathogenesis of chronic hepatitis B. World J Gastroenterol 20:39 (2014), 14156–14171.
4. [4] Hunter, C.A., New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:7 (2005), 521–531.
5. [5] Jain, R., Chen, Y., Kanno, Y., Joyce-Shaikh, B., Vahedi, G., Hirahara, K., et al. Interleukin-23-induced transcription factor blimp-1 promotes pathogenicity of T helper 17 cells. Immunity 44:1 (2016), 131–142.
6. [6] Espigol-Frigole, G., Planas-Rigol, E., Ohnuki, H., Salvucci, O., Kwak, H., Ravichandran, S., et al. Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling. Sci Signal, 9(419), 2016, ra28.
7. [7] Saadoun, D., Garrido, M., Comarmond, C., Desbois, A.C., Domont, F., Savey, L., et al. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis. Arthritis Rheumatol 67:5 (2015), 1353–1360.
8. [8] Cua, D.J., Sherlock, J., Chen, Y., Murphy, C.A., Joyce, B., Seymour, B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:6924 (2003), 744–748.
9. [9] Sutton, C.E., Lalor, S.J., Sweeney, C.M., Brereton, C.F., Lavelle, E.C., Mills, K.H., Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31:2 (2009), 331–341.
10. [10] Xia, L., Tian, D., Huang, W., Zhu, H., Wang, J., Zhang, Y., et al. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-kappaB pathway. J Immunol 188:2 (2012), 753–764.
11. [11] European Association for the Study of the L, EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:1 (2012), 167–185.
12. [12] Sarin, S.K., Kedarisetty, C.K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A.C., et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int 8:4 (2014), 453–471.
13. [13] Kamath, P.S., Wiesner, R.H., Malinchoc, M., Kremers, W., Therneau, T.M., Kosberg, C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33:2 (2001), 464–470.
14. [14] Li, N., Chen, M.Q., Qian, Z.P., Zhu, M.Q., Li, Q., Zheng, J.M., et al. Correlation of the expression of toll-like receptors in monocyte-derived dendritic cells with prognosis of chronic severe hepatitis B. J Dig Dis 12:2 (2011), 117–124.
15. [15] Mise-Omata, S., Obata, Y., Doi, T.S., p100, a precursor of NF-kappaB2, inhibits c-Rel and reduces the expression of IL-23 in dendritic cells. Biochem Biophys Res Commun 453:3 (2014), 332–337.
16. [16] Carmody, R.J., Ruan, Q., Liou, H.C., Chen, Y.H., Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J Immunol 178:1 (2007), 186–191.
17. [17] Brain, O., Owens, B.M., Pichulik, T., Allan, P., Khatamzas, E., Leslie, A., et al. The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity 39:3 (2013), 521–536.
18. [18] Langrish, C.L., McKenzie, B.S., Wilson, N.J., de Waal Malefyt, R., Kastelein, R.A., Cua, D.J., IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202 (2004), 96–105.
19. [19] Bi, Q.R., Hou, J.J., Qi, P., Ma, C.H., Shen, Y., Feng, R.H., et al. Venenum Bufonis induces rat neuroinflammation by activiating NF-kappaB pathway and attenuation of BDNF. J Ethnopharmacol 186 (2016), 103–110.
20. [20] Chantzoura, E., Prinarakis, E., Panagopoulos, D., Mosialos, G., Spyrou, G., Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling. Biochem Biophys Res Commun 403:3–4 (2010), 335–339.
21. [21] Wang, X., Wang, J., Liu, H., Xu, R., Ding, R., Jiang, S., et al. TRAF6 is required for BLyS-mediated NF-kappaB signaling in multiple myeloma cells. Med Oncol, 32(10), 2015, 671.
22. [22] vom Dahl, S., Kircheis, G., Haussinger, D., Hepatic encephalopathy as a complication of liver disease. World J Gastroenterol 7:2 (2001), 152–156.
23. [23] Zhang, J.Y., Zhang, Z., Lin, F., Zou, Z.S., Xu, R.N., Jin, L., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51:1 (2010), 81–91.
24. [24] Abbas, A., Gregersen, I., Holm, S., Daissormont, I., Bjerkeli, V., Krohg-Sorensen, K., et al. Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis. Stroke 46:3 (2015), 793–799.
25. [25] Zaky, D.S., El-Nahrery, E.M., Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity. Int Immunopharmacol 31 (2016), 105–108.